Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| FMR LLC | BRO Brown & Brown, Inc. | 13G | 5.4% | Jun 30, 2026 | 3mo |
| FMR LLC | EWTX Edgewise Therapeutics, Inc. | 13G | 5.1% | Jun 30, 2026 | 3mo |
| FMR LLC | MIRM Mirum Pharmaceuticals, Inc. | 13G | 6.2% | Jun 30, 2026 | 3mo |
| Grantham, Mayo, Van Otterloo & Co. LLC | CLNE Clean Energy Fuels Corp. | 13G/A | 4.96% | Jun 30, 2026 | 3mo |
| FMR LLC | UCB United Community Banks Inc | 13G/A | 6.7% | Jun 30, 2026 | 3mo |
| FMR LLC | ASHR DBX ETF Trust | 13G/A | 7.6% | Jun 30, 2026 | 3mo |
| BERKLEY W R CORP | UYSC UY Scuti Acquisition Corp. | 13G/A | 7.8% | Jun 30, 2026 | 3mo |
| FIL Ltd | AQN Algonquin Power & Utilities Corp. | 13G | 5.1% | Jun 30, 2026 | 3mo |
| FMR LLC | FCPT Four Corners Property Trust, Inc. | 13G/A | 6.5% | Jun 30, 2026 | 3mo |
| Orilla Asset Management, S.L. | WBX Wallbox N.V. | 13D/A | 10.7% | Jun 30, 2026 | 3mo |
| FMR LLC | ELVN Enliven Therapeutics, Inc. | 13G/A | 15% | Jun 30, 2026 | 3mo |
| FMR LLC | APH Amphenol Corp | 13G/A | 5.7% | Jun 30, 2026 | 3mo |
| FMR LLC | EYE National Vision Holdings, Inc. | 13G | 5.1% | Jun 30, 2026 | 3mo |
| FMR LLC | BROS Dutch Bros Inc. | 13G/A | 12.2% | Jun 30, 2026 | 3mo |
| FMR LLC | INTA Intapp, Inc. | 13G/A | 6.6% | Jun 30, 2026 | 3mo |
| FMR LLC | KRMN Karman Holdings Inc. | 13G/A | 5.2% | Jun 30, 2026 | 3mo |
| FMR LLC | VOYA Voya Financial, Inc. | 13G/A | 1.3% | Jun 30, 2026 | 3mo |
| FMR LLC | HLMN Hillman Solutions Corp. | 13G/A | 9% | Jun 30, 2026 | 3mo |
| FMR LLC | ACHC Acadia Healthcare Company, Inc. | 13G/A | 5.5% | Jun 30, 2026 | 3mo |
| FMR LLC | AVTX Avalo Therapeutics, Inc. | 13G/A | 9.7% | Jun 30, 2026 | 3mo |
| FIL Ltd | HUYA HUYA Inc. | 13G/A | 4.2% | Jun 30, 2026 | 3mo |
| BERKLEY W R CORP | MACI Melar Acquisition Corp. I | 13G/A | 8.3% | Jun 30, 2026 | 3mo |
| FMR LLC | GTX Garrett Motion Inc. | 13G | 8.9% | Jun 30, 2026 | 3mo |
| FMR LLC | MDLN Medline Inc. | 13G | 5.5% | Jun 30, 2026 | 3mo |
| FMR LLC | AVR Anteris Technologies Global Corp. | 13G | 7.5% | Jun 30, 2026 | 3mo |
| FMR LLC | MTX Minerals Technologies Inc | 13G/A | 15% | Jun 30, 2026 | 3mo |
| FMR LLC | GFL GFL Environmental Inc. | 13G/A | 6.5% | Jun 30, 2026 | 3mo |
| FMR LLC | SLDB Solid Biosciences Inc. | 13G | 7% | Jun 30, 2026 | 3mo |
| FMR LLC | TWST Twist Bioscience Corp | 13G | 7.6% | Jun 30, 2026 | 3mo |
| FMR LLC | NTRS Northern Trust Corp | 13G/A | 4.7% | Jun 30, 2026 | 3mo |
| FMR LLC | GTM ZoomInfo Technologies Inc. | 13G/A | 2.3% | Jun 30, 2026 | 3mo |
| FMR LLC | FN Fabrinet | 13G/A | 5.1% | Jun 30, 2026 | 3mo |
| MILLENNIUM MANAGEMENT LLC | SUPN Supernus Pharmaceuticals, Inc. | 13G/A | 6.6% | Jun 30, 2026 | 3mo |
| BERKLEY W R CORP | IPCX Inflection Point Acquisition Corp. III | 13G/A | 8.5% | Jun 30, 2026 | 3mo |
| FMR LLC | CROX Crocs, Inc. | 13G/A | 7.1% | Jun 30, 2026 | 3mo |
| FMR LLC | WST West Pharmaceutical Services Inc | 13G | 5% | Jun 30, 2026 | 3mo |
| FMR LLC | CBU Community Financial System, Inc. | 13G/A | 7% | Jun 30, 2026 | 3mo |
| FIL Ltd | RCI Rogers Communications Inc | 13G/A | 4.5% | Jun 30, 2026 | 3mo |
| BERKLEY W R CORP | HDRN Hadron Energy, Inc. | 13G/A | 0% | Jun 30, 2026 | 3mo |
| FMR LLC | OXM Oxford Industries Inc | 13G/A | 10% | Jun 30, 2026 | 3mo |
| FMR LLC | AORT Artivion, Inc. | 13G/A | 4% | Jun 30, 2026 | 3mo |
| FMR LLC | WDC Western Digital Corp | 13G/A | 7.2% | Jun 30, 2026 | 3mo |
| Millennium Management LLC | IMUX Immunic, Inc. | 13G/A | 7% | Jun 30, 2026 | 3mo |
| FMR LLC | GPK Graphic Packaging Holding Co | 13G | 5.9% | Jun 30, 2026 | 3mo |
| FMR LLC | FLEX Flex Ltd. | 13G | 5.3% | Jun 30, 2026 | 3mo |
| FIL Ltd | BKF iShares, Inc. | 13G/A | 1.2% | Jun 30, 2026 | 3mo |
| FMR LLC | BELFA Bel Fuse Inc | 13G/A | 7.1% | Jun 30, 2026 | 3mo |
| FMR LLC | ALM Almonty Industries Inc. | 13G/A | 9.6% | Jun 30, 2026 | 3mo |
| FMR LLC | MRNA Moderna, Inc. | 13G/A | 13.1% | Jun 30, 2026 | 3mo |
| FMR LLC | IFRX InflaRx N.V. | 13G | 5.5% | Jun 30, 2026 | 3mo |